Iovance

尽管华尔街分析师为部分今年表现惨淡的生物科技股勾勒出惊人的上涨蓝图，但投资者或许不应过于兴奋。基因编辑公司Intellia Therapeutics（$Intellia(NTLA)$）与细胞疗法公司Iovance Biotherapeutics（$Iovance(IOVA)$）虽具创新性，但各自面临严峻挑战，年内股价分别下跌19%和61%。
然而，根据...

$Iovance(IOVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-118168  Size: 15 KB 网页链接

$Iovance(IOVA)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-25-110493  Act: 33  Size: 183 KB 网页链接

$Iovance(IOVA)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-26-002323  Act: 34  Size: 8 MB 网页链接

$Iovance(IOVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-118167  Size: 9 KB 网页链接

$Iovance(IOVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-118169  Size: 15 KB 网页链接

$Iovance(IOVA)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001104659-25-110496  Act: 33  Size: 176 KB 网页链接

$Iovance(IOVA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-25-118170  Size: 15 KB 网页链接